NZDSZQDAROFNLP-UHFFFAOYSA-N
C34H39F3N8O2S — CID 130376021
Data last refreshed: (MolForge compound catalog, from PubChem)
About NZDSZQDAROFNLP-UHFFFAOYSA-N
NZDSZQDAROFNLP-UHFFFAOYSA-N (PubChem CID 130376021) has the molecular formula C34H39F3N8O2S and a molecular weight of 680.80 g/mol. Its IUPAC name is N-[1-[2-[2-cyano-6-methoxy-5-[[4-[[6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]piperidin-1-yl]methyl]indol-1-yl]ethyl]piperidin-4-yl]prop-2-enamide.
Molecular Properties
| Compound Name | NZDSZQDAROFNLP-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 130376021 |
| Molecular Formula | C34H39F3N8O2S |
| Molecular Weight | 680.80 g/mol |
| Exact Mass | 680.29 |
| IUPAC Name | N-[1-[2-[2-cyano-6-methoxy-5-[[4-[[6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]piperidin-1-yl]methyl]indol-1-yl]ethyl]piperidin-4-yl]prop-2-enamide |
| SMILES | C=CC(=O)NC1CCN(CCn2c(C#N)cc3cc(CN4CCC(Nc5ncnc6sc(CC(F)(F)F)cc56)CC4)c(OC)cc32)CC1 |
| InChI | InChI=1S/C34H39F3N8O2S/c1-3-31(46)41-24-4-8-43(9-5-24)12-13-45-26(19-38)15-22-14-23(30(47-2)17-29(22)45)20-44-10-6-25(7-11-44)42-32-28-16-27(18-34(35,36)37)48-33(28)40-21-39-32/h3,14-17,21,24-25H,1,4-13,18,20H2,2H3,(H,41,46)(H,39,40,42) |
| InChIKey | NZDSZQDAROFNLP-UHFFFAOYSA-N |
| XLogP | 5.47 |
| TPSA | 111.34 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 48 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 680.80 |
| LogP ≤ 5 | 5.47 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 130376021 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.